- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
6
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
6 companies
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.87
7D
1.4%
1Y
-27.4%
Oxford Nanopore Technologies
Market Cap: UK£1.1b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.13
7D
-4.2%
1Y
-7.7%
Animalcare Group
Market Cap: UK£228.9m
Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.
ANCR
UK£3.32
7D
0%
1Y
20.5%
Faron Pharmaceuticals Oy
Market Cap: UK£97.6m
Operates as a clinical stage drug discovery and development company.
FARN
UK£0.44
7D
-2.2%
1Y
-77.7%
Bioventix
Market Cap: UK£91.2m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£18.00
7D
8.8%
1Y
-33.3%
OptiBiotix Health
Market Cap: UK£6.1m
A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.
OPTI
UK£0.059
7D
-4.0%
1Y
-47.7%